Analysts Reiterate Gilead and Mylan at Buy

Here are today's top Wall Street analyst ratings where's unbiased fair value estimates support the recommendation.

Top Upgrades and Buy Ratings

  • RBC Capital Markets reiterated Gilead Sciences (Nasdaq:GILD) at Buy along with a $90 price target. data also implies that shares are trading far from intrinsic value. ‘GILD

  • BTIG Research reiterated Mylan N.V. (Nasdaq:MYL) at Buy along with a $55 price target. Five valuation models also imply a fair value of approximately $55 per share. ‘MYL

  • Standpoint Research initiated coverage on Vodafone Group (LSE:VOD) at Accumulate. Six valuation models imply a fair value of $34.35 per share representing over 35% upside. ‘VOD

  • RBC Capital Markets reiterated Mobileye N.V. (NYSE:MBLY) at Buy along with a $51 per share price target. The buy rating and price target are generally supported by the company's underlying fundamentals. ‘MBLY

Top Downgrades and Sell Ratings

  • Nomura and Instinet both downgraded Xilinx (Nasdaq:XLNX) from Neutral to Reduce. Shares are currently trading at a large premium. ‘XLNX

  • Barclays reiterated Cummins (NYSE:CMI) at Underweight. Nine valuation models imply the stock is 17% overvalued.

  • Aegis initiated coverage on Twitter (NYSE:TWTR) at Sell and set a $14 per share target price.'s fair value estimate is right in line with the $14 target. ‘TWTR

  • Bank of America downgrades Ryanair Holdings (ISE:RYAAY) from Neutral to Underperform. Ten separate valuation analyses conclude that the company currently has a negative 14% margin of safety. ‘RYAAY

Get Started Now!